A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy Pain
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Ketamine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors iX Biopharma
- 08 Sep 2017 Planned End Date changed from 28 Feb 2018 to 28 Mar 2018.
- 08 Sep 2017 Planned primary completion date changed from 28 Feb 2018 to 28 Mar 2018.
- 08 Sep 2017 Status changed from not yet recruiting to recruiting.